2.要約四半期連結財務諸表及び主な注記
(1)要約四半期連結財政状態計算書
| | (単位:百万円) |
| 前連結会計年度 (2024年12月31日) | 当第3四半期連結会計期間 (2025年9月30日) |
資産 | | |
流動資産 | | |
現金及び現金同等物 | 886 | 1,832 |
営業債権及びその他の債権 | 232 | 75 |
棚卸資産 | 128 | 138 |
その他の流動資産 | 19 | 29 |
流動資産合計 | 1,266 | 2,076 |
非流動資産 | | |
有形固定資産 | 19 | 17 |
使用権資産 | 28 | 105 |
持分法で会計処理されている投資 | 1 | 1 |
その他の金融資産 | 46 | 139 |
非流動資産合計 | 96 | 264 |
資産合計 | 1,362 | 2,340 |
| | |
負債及び資本 | | |
負債 | | |
流動負債 | | |
営業債務及びその他の債務 | 121 | 378 |
リース負債 | 25 | 31 |
その他の流動負債 | 47 | 44 |
流動負債合計 | 193 | 454 |
非流動負債 | | |
繰延税金負債 | 0 | 5 |
リース負債 | 0 | 73 |
その他の非流動負債 | 10 | 11 |
非流動負債合計 | 12 | 89 |
負債合計 | 206 | 543 |
資本 | | |
資本金 | 2,211 | 788 |
資本剰余金 | 2,255 | 1,408 |
利益剰余金 | △3,277 | △370 |
自己株式 | △65 | △65 |
その他の資本の構成要素 | 33 | 36 |
資本合計 | 1,156 | 1,796 |
負債及び資本合計 | 1,362 | 2,340 |
E3304445970ソレイジア・ファーマ株式会社Solasia Pharma K.K.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2025-01-012025-09-30Q32025-12-312024-01-012024-09-302024-12-311falsefalsefalse459702024-12-31jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember459702025-01-012025-09-30jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember459702025-09-30jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember459702023-12-31jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember459702024-01-012024-09-30jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember459702024-09-30jpigp_cor:NetChangeInFairValueOfEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember459702023-12-31459702024-12-31459702024-01-012024-09-30459702024-09-30459702025-01-012025-09-30459702025-09-30459702025-11-14459702023-12-31jpigp_cor:ShareCapitalIFRSMember459702023-12-31jpigp_cor:CapitalSurplusIFRSMember459702023-12-31jpigp_cor:RetainedEarningsIFRSMember459702023-12-31jpigp_cor:TreasurySharesIFRSMember459702023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember459702023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember459702023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember459702024-12-31jpigp_cor:ShareCapitalIFRSMember459702024-12-31jpigp_cor:CapitalSurplusIFRSMember459702024-12-31jpigp_cor:RetainedEarningsIFRSMember459702024-12-31jpigp_cor:TreasurySharesIFRSMember459702024-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember459702024-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember459702024-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember459702024-01-012024-09-30jpigp_cor:ShareCapitalIFRSMember459702024-01-012024-09-30jpigp_cor:CapitalSurplusIFRSMember459702024-01-012024-09-30jpigp_cor:RetainedEarningsIFRSMember459702024-01-012024-09-30jpigp_cor:TreasurySharesIFRSMember459702024-01-012024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember459702024-01-012024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember459702024-01-012024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember459702024-09-30jpigp_cor:ShareCapitalIFRSMember459702024-09-30jpigp_cor:CapitalSurplusIFRSMember459702024-09-30jpigp_cor:RetainedEarningsIFRSMember459702024-09-30jpigp_cor:TreasurySharesIFRSMember459702024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember459702025-01-012025-09-30jpigp_cor:CapitalSurplusIFRSMember459702024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember459702024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember459702025-01-012025-09-30jpigp_cor:ShareCapitalIFRSMember459702025-01-012025-09-30jpigp_cor:RetainedEarningsIFRSMember459702025-01-012025-09-30jpigp_cor:TreasurySharesIFRSMember459702025-01-012025-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember459702025-01-012025-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember459702025-01-012025-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember459702025-09-30jpigp_cor:ShareCapitalIFRSMember459702025-09-30jpigp_cor:CapitalSurplusIFRSMember459702025-09-30jpigp_cor:RetainedEarningsIFRSMember459702025-09-30jpigp_cor:TreasurySharesIFRSMember459702025-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember459702025-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember459702025-09-30jpigp_cor:ShareAcquisitionRightsIFRSMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure